These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

335 related items for PubMed ID: 23529662

  • 1. MicroRNA-29a protects against glucocorticoid-induced bone loss and fragility in rats by orchestrating bone acquisition and resorption.
    Wang FS, Chuang PC, Lin CL, Chen MW, Ke HJ, Chang YH, Chen YS, Wu SL, Ko JY.
    Arthritis Rheum; 2013 Jun; 65(6):1530-40. PubMed ID: 23529662
    [Abstract] [Full Text] [Related]

  • 2. MicroRNA-29a mitigates glucocorticoid induction of bone loss and fatty marrow by rescuing Runx2 acetylation.
    Ko JY, Chuang PC, Ke HJ, Chen YS, Sun YC, Wang FS.
    Bone; 2015 Dec; 81():80-88. PubMed ID: 26141838
    [Abstract] [Full Text] [Related]

  • 3. MicroRNA-29a ameliorates glucocorticoid-induced suppression of osteoblast differentiation by regulating β-catenin acetylation.
    Ko JY, Chuang PC, Chen MW, Ke HC, Wu SL, Chang YH, Chen YS, Wang FS.
    Bone; 2013 Dec; 57(2):468-75. PubMed ID: 24096265
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of glycogen synthase kinase-3beta attenuates glucocorticoid-induced bone loss.
    Wang FS, Ko JY, Weng LH, Yeh DW, Ke HJ, Wu SL.
    Life Sci; 2009 Nov 04; 85(19-20):685-92. PubMed ID: 19782693
    [Abstract] [Full Text] [Related]

  • 5. Heat shock protein 60 protects skeletal tissue against glucocorticoid-induced bone mass loss by regulating osteoblast survival.
    Wang FS, Wu RW, Ko JY, Tai MH, Ke HC, Yeh DW, Wu SL, Chen MW.
    Bone; 2011 Nov 04; 49(5):1080-9. PubMed ID: 21854881
    [Abstract] [Full Text] [Related]

  • 6. Cannabinoid receptor 1 mediates glucocorticoid-induced bone loss in rats by perturbing bone mineral acquisition and marrow adipogenesis.
    Ko JY, Wu RW, Kuo SJ, Chen MW, Yeh DW, Ke HC, Wu SL, Wang FS.
    Arthritis Rheum; 2012 Apr 04; 64(4):1204-14. PubMed ID: 22127784
    [Abstract] [Full Text] [Related]

  • 7. MicroRNA-29a Counteracts Glucocorticoid Induction of Bone Loss through Repressing TNFSF13b Modulation of Osteoclastogenesis.
    Wu RW, Lian WS, Chen YS, Kuo CW, Ke HC, Hsieh CK, Wang SY, Ko JY, Wang FS.
    Int J Mol Sci; 2019 Oct 17; 20(20):. PubMed ID: 31627291
    [Abstract] [Full Text] [Related]

  • 8. MicroRNA-29a represses osteoclast formation and protects against osteoporosis by regulating PCAF-mediated RANKL and CXCL12.
    Lian WS, Ko JY, Chen YS, Ke HJ, Hsieh CK, Kuo CW, Wang SY, Huang BW, Tseng JG, Wang FS.
    Cell Death Dis; 2019 Sep 23; 10(10):705. PubMed ID: 31543513
    [Abstract] [Full Text] [Related]

  • 9. A novel flavonoid C-glucoside from Ulmus wallichiana preserves bone mineral density, microarchitecture and biomechanical properties in the presence of glucocorticoid by promoting osteoblast survival: a comparative study with human parathyroid hormone.
    Khan MP, Mishra JS, Sharan K, Yadav M, Singh AK, Srivastava A, Kumar S, Bhaduaria S, Maurya R, Sanyal S, Chattopadhyay N.
    Phytomedicine; 2013 Nov 15; 20(14):1256-66. PubMed ID: 23928508
    [Abstract] [Full Text] [Related]

  • 10. Piezoelectric Microvibration Mitigates Estrogen Loss-Induced Osteoporosis and Promotes Piezo1, MicroRNA-29a, and Wnt3a Signaling in Osteoblasts.
    Wu RW, Lian WS, Chen YS, Ko JY, Wang SY, Jahr H, Wang FS.
    Int J Mol Sci; 2021 Aug 31; 22(17):. PubMed ID: 34502380
    [Abstract] [Full Text] [Related]

  • 11. MicroRNA-17/20a inhibits glucocorticoid-induced osteoclast differentiation and function through targeting RANKL expression in osteoblast cells.
    Shi C, Qi J, Huang P, Jiang M, Zhou Q, Zhou H, Kang H, Qian N, Yang Q, Guo L, Deng L.
    Bone; 2014 Nov 31; 68():67-75. PubMed ID: 25138550
    [Abstract] [Full Text] [Related]

  • 12. Estradiol protects against ethanol-induced bone loss by inhibiting up-regulation of receptor activator of nuclear factor-kappaB ligand in osteoblasts.
    Chen JR, Haley RL, Hidestrand M, Shankar K, Liu X, Lumpkin CK, Simpson PM, Badger TM, Ronis MJ.
    J Pharmacol Exp Ther; 2006 Dec 31; 319(3):1182-90. PubMed ID: 16971503
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation.
    Häusler KD, Horwood NJ, Chuman Y, Fisher JL, Ellis J, Martin TJ, Rubin JS, Gillespie MT.
    J Bone Miner Res; 2004 Nov 31; 19(11):1873-81. PubMed ID: 15476588
    [Abstract] [Full Text] [Related]

  • 16. miR-29a promotes osteoblast proliferation by downregulating DKK-1 expression and activating Wnt/β-catenin signaling pathway.
    Zhang F, Cao K, Du G, Zhang Q, Yin Z.
    Adv Clin Exp Med; 2019 Oct 31; 28(10):1293-1300. PubMed ID: 31538414
    [Abstract] [Full Text] [Related]

  • 17. Thyroid-stimulating hormone restores bone volume, microarchitecture, and strength in aged ovariectomized rats.
    Sampath TK, Simic P, Sendak R, Draca N, Bowe AE, O'Brien S, Schiavi SC, McPherson JM, Vukicevic S.
    J Bone Miner Res; 2007 Jun 31; 22(6):849-59. PubMed ID: 17352644
    [Abstract] [Full Text] [Related]

  • 18. Modulation of Dickkopf-1 attenuates glucocorticoid induction of osteoblast apoptosis, adipocytic differentiation, and bone mass loss.
    Wang FS, Ko JY, Yeh DW, Ke HC, Wu HL.
    Endocrinology; 2008 Apr 31; 149(4):1793-801. PubMed ID: 18174290
    [Abstract] [Full Text] [Related]

  • 19. Secreted frizzled-related protein 1 modulates glucocorticoid attenuation of osteogenic activities and bone mass.
    Wang FS, Lin CL, Chen YJ, Wang CJ, Yang KD, Huang YT, Sun YC, Huang HC.
    Endocrinology; 2005 May 31; 146(5):2415-23. PubMed ID: 15677765
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.